Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients

N/AWithdrawnNCT03003143

Seoul National University Hospital

Overview

Investigation of efficacy of vigabatrin in refractory autoimmune encephalitis patients

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Conditions

Autoimmune Encephalopathy

Interventions

Vigabatrin 500 MGDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18-85 * Possible autoimmune encephalitis * Patients who have been diagnosed and treated for encephalitis for more than 4 weeks * Patients with epilepsy (EEG finding or clinically) Exclusion Criteria: * septic shock, fever \>38.5 ℃, O2 saturation \<90%, respiratory rate \>25, HR \>120 * previously, mRS=3 or mRS\>3 * MMSE\<20 * Patients who have terminal disease * eye problem * pregnancy

Locations (1)

Seoul National University Hospital

Seoul, South Korea